Safety and Efficacy of Intralesional HiLow Hyaluronic Acid in the Treatment of Peyronie's Disease (PD)

Inclusion Criteria: * basal degree of penile curvature not less than 30° * preserved erection * documented absence of coagulation defects (at least one examination of coagulation factors within the 3 months prior to the start of the study) * written informed consent Exclusion Criteria: * presence of hourglass deformity * presence of calcified plaques * congenital curvature of the penis * previous penile surgery * concomitant oral treatment for IPP * ongoing intralesional therapy or in the 3 months prior to the start of the study * use of any traction device * clinically stable disease * history of symptomatic disease \> 12 months * known hypersensitivity or allergies to the components of the product * any other clinical condition judged by the investigator not to be compatible with the participation in this study